216
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Assessment of the Persistence in the Human Intestinal Tract of Two Probiotic Lactobacilli Lactobacillus salivarius I 1794 and Lactobacillus paracasei I 1688

, &
Pages 229-233 | Published online: 25 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

A. M. Castellazzi, C. Valsecchi, L. Montagna, P. Malfa, G. Ciprandi, M. A. Avanzini & G. L. Marseglia. (2007) In vitro Activation of Mononuclear Cells by Two Probiotics: Lactobacillus paracasei I 1688, Lactobacillus salivarius I 1794, and their Mixture (PSMIX). Immunological Investigations 36:4, pages 413-421.
Read now

Articles from other publishers (8)

Anne-Sophie Alvarez, Julien Tap, Isabelle Chambaud, Stéphanie Cools-Portier, Laurent Quinquis, Pierre Bourlioux, Philippe Marteau, Eric Guillemard, Juergen Schrezenmeir & Muriel Derrien. (2020) Safety and functional enrichment of gut microbiome in healthy subjects consuming a multi-strain fermented milk product: a randomised controlled trial. Scientific Reports 10:1.
Crossref
Erin E. Donaldson, Dragana Stanley, Robert J. Hughes & Robert J. Moore. (2017) The time-course of broiler intestinal microbiota development after administration of cecal contents to incubating eggs. PeerJ 5, pages e3587.
Crossref
Ingemar von Ossowski, Taija E. Pietilä, Johanna Rintahaka, Elina Nummenmaa, Veli-Matti Mäkinen, Justus Reunanen, Reetta Satokari, Willem M. de Vos, Ilkka Palva & Airi Palva. (2013) Using Recombinant Lactococci as an Approach to Dissect the Immunomodulating Capacity of Surface Piliation in Probiotic Lactobacillus rhamnosus GG. PLoS ONE 8:5, pages e64416.
Crossref
. (2012) Scientific Opinion on the substantiation of health claims related to various microorganisms and reduction of gastro-intestinal discomfort (ID 1030, 2956, 2958, 2961, 2963, 2966, 2970), decreasing potentially pathogenic gastro-intestinal microorganisms (ID. EFSA Journal 10:8, pages 2858.
Crossref
. (2012) Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus paracasei CNCM I-1688 and Lactobacillus salivarius CNCM I-1794 and reduction of gastro-intestinal discomfort (ID 2972), decreasing potentially pathogenic g. EFSA Journal 10:8, pages 2856.
Crossref
Eamonn MM Quigley. (2011) Gut microbiota and the role of probiotics in therapy. Current Opinion in Pharmacology 11:6, pages 593-603.
Crossref
Eamonn M.M. Quigley. (2011) Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies. Gastroenterology Clinics of North America 40:1, pages 207-222.
Crossref
. (2009) Scientific Opinion on the substantiation of health claims related to non characterised microorganisms pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 7:10, pages 1247.
Crossref